GENOME-SCALE METHYLATION ANALYSIS IN BLOOD AND TUMOR IDENTIFIES IMMUNE PROFILE, AGE ACCELERATION, AND DNA METHYLATION ALTERATIONS ASSOCIATED WITH BLADDER CANCER OUTCOMES